Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. recalls Abilify (aripiprazole), 15 mg tablets, packaged in 30 count bottles, RX only, Otsuka America…

Cross Contamination with Other Products

Date

2024-05-01

Country

United States

Brand

Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.

Product

Abilify (aripiprazole), 15 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-009-13

Classification

Class III

Units

USA nationwide.

Category

Drugs & medical

Source

FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

1. Check the product name, strength and lot number against the official notice.
2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in the United States

1. 2024-05-01
2. US
   Drugs & medicalClass II

   Glenmark Pharmaceuticals Inc., USA recalls Diltiazem Hydrochloride Extended-Release Capsules, USP 120 mg, Twice-a-Day Dosage, 100 Capsules per bottle, Rx Only,…

   Failed Dissolution Specifications

   FDA · DrugGlenmark Pharmaceuticals Inc., USANationwide in the USA.Official notice →
3. US
   Drugs & medicalClass II

   Cipla USA, Inc. recalls Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP, 0.5 mg & 3mg/3mL unit-dose vials, packaged in carton containing 30…

   Short fill: Complaints received of less fill volume in respule and few drops of liquid observed in the intact pouch.

   FDA · DrugCipla USA, Inc.USA nationwide.Official notice →
4. US
   Drugs & medicalClass I

   FA Online Inc recalls ForeverMen Natural Energy Boost Capsules, packaged in a box containing a 10-count blister card.

   Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared sildenafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this unapproved drug.

   FDA · DrugFA Online IncUSA Nationwide. The product was sold via Amazon Market Place.Official notice →
5. US
   Drugs & medicalClass II

   Nomax Inc recalls GloStrips, Fluorescein Sodium Ophthalmic Strips USP (0.6 mg Fluorescein), Rx Only, a) 100 strips per carton, NDC 51801-003-40; b) 300…

   Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.

   FDA · DrugNomax IncNationwide in the USAOfficial notice →
6. US
   Drugs & medicalClass II

   HONEYWELL INC recalls Eyesaline, Saline Eyewash Solution, Cartridge for Fendall 2000, Net contents: 7.9 gal per cartridge, Sperian Eye & Face Protection, Inc.,…

   CGMP Deviations

   FDA · DrugHONEYWELL INCNationwide USA, CanadaOfficial notice →
7. US
   Drugs & medicalClass I

   Aruba Aloe Balm N.V. recalls Alcoholada Gel, Pain Relieving Gel, 0.5% Lidocaine Hydrochloride, packaged in (a) 8.5 fl oz (251 mL) plastic bottle UPC 0 82252 03120 9…

   Chemical Contamination: Product manufactured with ethanol API that contains methanol

   FDA · DrugAruba Aloe Balm N.V.Nationwide in the USAOfficial notice →